Sequential serologic testing for common viral markers in blood units in India is probably not cost-effective
First published: 02 August 2010
No abstract is available for this article.
REFERENCES
- 1
Kania D,
Sangare L,
Sakande J,
Koanda A,
Nebie YK,
Zerbo O,
Combassere AW,
Guisso IP,
Rouet F.
A new strategy to improve cost effectiveness of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis testing of blood donation in sub Saharan Africa: a pilot study in Burkina Faso.
Transfusion
2009; 49: 2237-40.
- 2
Nanu A,
Sharma SP,
Chatterjee K,
Jyoti P.
Markers for transfusion-transmissible infections in north Indian voluntary and replacement blood donors: prevalence and trends 1989-96.
Vox Sang
1997; 73: 70-3.
- 3
Garg S,
Mathur DR,
Garg DK.
Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary donors in western India.
Indian J Pathol Microbiol
2001; 44: 409-12.
- 4
Sharma RR,
Cheema R,
Vajpayee M,
Rao U,
Kumar S,
Marwaha N,
Agnihotri SK.
Prevalence of markers of transfusion transmissible diseases in voluntary and replacement blood donors.
Natl Med J India
2004; 17: 19-21.
- 5
Singh B,
Verma B,
Kotru M,
Verma K,
Batra B.
Prevalence of HIV and VDRL positivity in blood donors of Delhi.
Indian J Med Res
2005; 122: 234-36.
- 6
Kafi-Abad S,
Rezvan H,
Abolghasemi H,
Talebian A.
Prevalence and trends of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among blood donors in Iran, 2004 through 2007.
Transfusion
2009; 49: 2214-20.
